サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1788338

センチネルリンパ節生検の世界市場

Sentinel Node Biopsy

出版日
ページ情報
英文 203 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.16円
センチネルリンパ節生検の世界市場
出版日: 2025年08月12日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 203 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

センチネルリンパ節生検の世界市場は2030年までに13億米ドルに達する見込み

2024年に8億2,930万米ドルと推定されるセンチネルリンパ節生検の世界市場は、分析期間2024-2030年にCAGR 7.1％で成長し、2030年には13億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである外科用器具は、CAGR 7.9％を記録し、分析期間終了時には7億3,220万米ドルに達すると予測されます。イメージング剤セグメントの成長率は、分析期間でCAGR 6.2％と推定されます。

米国市場は2億1,800万米ドルと推定、中国はCAGR6.9％で成長予測

米国のセンチネルリンパ節生検市場は、2024年に2億1,800万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを6.9%として、2030年には予測市場規模2億30万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.7%と5.9%と予測されています。欧州では、ドイツがCAGR 5.6%で成長すると予測されています。

世界のセンチネルリンパ節生検市場- 主要動向と促進要因のまとめ

なぜセンチネルリンパ節生検はがん診断において重要な手順となりつつあるのか？

センチネルリンパ節生検（SNB）は、特に乳がんやメラノーマの場合、がんの広がりを判断するために使用される低侵襲の外科手術です。がん細胞が到達しそうな最初のリンパ節（センチネルリンパ節）を特定して分析することで、SNBは医師がリンパ節全切除を必要とせずに転移を評価するのに役立ちます。この手法は、高い診断精度を維持しながらリンパ浮腫などの合併症を軽減できることから、人気を集めています。がんの罹患率が世界的に上昇し、早期発見が生存率の向上に重要な役割を果たす中、センチネルリンパ節生検手技に対する需要はヘルスケア機関全体で高まっています。さらに、画像診断や分子診断の進歩により、SNBの精度と信頼性がさらに向上しています。

どのような技術革新がセンチネルリンパ節生検手技を向上させているか？

放射性トレーサー技術、蛍光ガイド下手術、分子イメージングにおける最近の進歩は、センチネルリンパ節生検に革命をもたらしています。放射性染料と蛍光染料を組み合わせたハイブリッドトレーサーの使用により、検出率が向上し、外科医はセンチネルリンパ節の位置を正確に特定できるようになりました。AIによる病理解析は、生検結果の精度をさらに高め、より良いがんの病期分類と治療計画の立案につながっています。さらに、ロボット支援センチネルリンパ節生検は、精度を向上させ、患者の外傷を最小限にするために研究されています。このような技術的飛躍的進歩により、SNBはより効率的で正確なものとなり、腫瘍科診療において広く利用されるようになっています。

センチネルリンパ節生検の成長を牽引する医療分野は？

乳がん診断は依然としてセンチネルリンパ節生検の主要アプリケーションであり、SNBは早期乳がん患者の標準治療となっています。皮膚科や腫瘍内科でも、リンパ節転移を正確に評価できるSNBをメラノーマの病期分類に活用しています。頭頸部がん、婦人科がん、前立腺がんにおける新たな応用により、SNBの使用はさらに拡大しています。さらに、新興市場のヘルスケアプロバイダーは、腫瘍学インフラへの投資の増加に支えられ、がん治療戦略の改善の一環としてSNBを採用しています。

センチネルリンパ節生検市場の成長を促進している要因は？

センチネルリンパ節生検市場の成長は、がん罹患率の増加、低侵襲診断手技の採用増加、画像技術の進歩によって牽引されています。がんの早期発見を促進する政府の取り組みや、腫瘍学診断へのアクセス向上が市場拡大をさらに後押ししています。さらに、病理学におけるAIと機械学習の統合がSNBの精度を高め、腫瘍医や外科医の需要を促進しています。精密医療が進化し続ける中、SNBは個別化されたがん治療と予後診断においてますます重要な役割を果たすと思われます。

セグメント

製品（手術器具、画像診断、診断キット）;手技（観血的手術、低侵襲手術）;用途（乳がん、大腸がん、食道がん、その他）;最終用途（病院・クリニック、外来手術センター、診断センター）

調査対象企業の例

  • BD（Becton, Dickinson and Company）
  • Boston Scientific Corporation
  • C.R. Bard, Inc.
  • Cardinal Health
  • Care Wise
  • Devicor Medical Products, Inc.
  • Devicor Medical Products, Inc.
  • Endomagnetics Ltd（Endomag）
  • Gamma Medical Technology
  • Gamma Probe Technologies
  • GE Healthcare
  • Hologic, Inc.
  • Hologic, Inc.
  • Intramedical Imaging LLC
  • IsoRay Medical
  • KUB Technologies Inc.
  • KUB Technologies Inc.
  • LabLogic Systems Ltd（Care Wise）
  • LabLogic Systems Ltd（Care Wise）
  • LymphaTech
  • Medtronic
  • Navidea Biopharmaceuticals, Inc.
  • Philips Healthcare
  • Senti Biosciences
  • Siemens Healthineers
  • Stryker Corporation
  • Stryker Corporation
  • SurgicEye GmbH
  • SurgicEye GmbH
  • Varay Laborix

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP32906

Global Sentinel Node Biopsy Market to Reach US$1.3 Billion by 2030

The global market for Sentinel Node Biopsy estimated at US$829.3 Million in the year 2024, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Surgical Instruments, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$732.2 Million by the end of the analysis period. Growth in the Imaging Agents segment is estimated at 6.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$218.0 Million While China is Forecast to Grow at 6.9% CAGR

The Sentinel Node Biopsy market in the U.S. is estimated at US$218.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$200.3 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global Sentinel Node Biopsy Market - Key Trends & Drivers Summarized

Why Is Sentinel Node Biopsy Becoming A Crucial Procedure In Cancer Diagnostics?

Sentinel node biopsy (SNB) is a minimally invasive surgical procedure used to determine the spread of cancer, particularly in cases of breast cancer and melanoma. By identifying and analyzing the first lymph node (sentinel node) that cancer cells are likely to reach, SNB helps physicians assess metastasis without requiring a full lymph node dissection. This technique is gaining popularity due to its ability to reduce complications such as lymphedema while maintaining high diagnostic accuracy. With cancer rates rising globally and early detection playing a critical role in improving survival rates, the demand for sentinel node biopsy procedures is growing across healthcare institutions. Additionally, advancements in imaging and molecular diagnostics are further improving SNB precision and reliability.

What Technological Innovations Are Enhancing Sentinel Node Biopsy Procedures?

Recent advancements in radiotracer technology, fluorescence-guided surgery, and molecular imaging are revolutionizing sentinel node biopsy. The use of hybrid tracers combining radioactive and fluorescent dyes is improving detection rates, allowing surgeons to precisely locate sentinel lymph nodes. AI-assisted pathology analysis is further enhancing the accuracy of biopsy results, leading to better cancer staging and treatment planning. Additionally, robotic-assisted sentinel node biopsies are being explored to improve precision and minimize patient trauma. These technological breakthroughs are making SNB more efficient, accurate, and widely accessible in oncology practices.

Which Medical Sectors Are Driving The Growth Of Sentinel Node Biopsy?

Breast cancer diagnosis remains the leading application of sentinel node biopsy, with SNB becoming the standard of care for early-stage breast cancer patients. Dermatology and oncology practices are also utilizing SNB for melanoma staging, as it allows for precise assessment of lymph node involvement. Emerging applications in head and neck cancer, gynecologic cancers, and prostate cancer are further expanding the use of SNB. Additionally, healthcare providers in emerging markets are adopting SNB as part of improved cancer care strategies, supported by growing investments in oncology infrastructure.

What Factors Are Fueling The Growth Of The Sentinel Node Biopsy Market?

The growth of the sentinel node biopsy market is being driven by increasing cancer prevalence, rising adoption of minimally invasive diagnostic procedures, and advancements in imaging technology. Government initiatives promoting early cancer detection and improved access to oncology diagnostics are further supporting market expansion. Additionally, the integration of AI and machine learning in pathology is enhancing SNB accuracy, driving demand among oncologists and surgeons. As precision medicine continues to evolve, SNB will play an increasingly crucial role in personalized cancer treatment and prognosis.

SCOPE OF STUDY:

The report analyzes the Sentinel Node Biopsy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Surgical Instruments, Imaging Agents, Diagnostic Kits); Procedure (Open Surgery, Minimally Invasive Surgery); Application (Breast Cancer, Colon Cancer, Esophageal Cancer, Others); End-Use (Hospitals & Clinics, Ambulatory Surgery Centers, Diagnostic Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 39 Featured) -

  • BD (Becton, Dickinson and Company)
  • Boston Scientific Corporation
  • C.R. Bard, Inc.
  • Cardinal Health
  • Care Wise
  • Devicor Medical Products, Inc.
  • Devicor Medical Products, Inc.
  • Endomagnetics Ltd (Endomag)
  • Gamma Medical Technology
  • Gamma Probe Technologies
  • GE Healthcare
  • Hologic, Inc.
  • Hologic, Inc.
  • Intramedical Imaging LLC
  • IsoRay Medical
  • KUB Technologies Inc.
  • KUB Technologies Inc.
  • LabLogic Systems Ltd (Care Wise)
  • LabLogic Systems Ltd (Care Wise)
  • LymphaTech
  • Medtronic
  • Navidea Biopharmaceuticals, Inc.
  • Philips Healthcare
  • Senti Biosciences
  • Siemens Healthineers
  • Stryker Corporation
  • Stryker Corporation
  • SurgicEye GmbH
  • SurgicEye GmbH
  • Varay Laborix

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Sentinel Node Biopsy - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Early Cancer Detection Drives Growth in Sentinel Node Biopsy Procedures
    • Surge in Cancer Incidence Rates Expands Market Opportunities for Sentinel Node Biopsy Technologies
    • Technological Advancements in Imaging and Tracers Propel the Accuracy and Effectiveness of Sentinel Node Biopsy
    • Rising Awareness Among Healthcare Providers and Patients of the Benefits of Minimally Invasive Procedures Accelerates Adoption of Sentinel Node Biopsy
    • The Shift Toward Personalized Medicine and Tailored Cancer Treatments Drives Demand for Sentinel Node Biopsy Solutions
    • Increasing Focus on Reducing Surgical Complications and Recovery Times Strengthens the Business Case for Sentinel Node Biopsy
    • Surge in Breast Cancer and Melanoma Cases Drives the Demand for Sentinel Node Biopsy in Oncology Treatments
    • Expansion of Cancer Immunotherapy and Targeted Therapies Fuels Market Growth for Sentinel Node Biopsy Procedures
    • Rising Investment in Advanced Cancer Diagnostics and Staging Technologies Expands Market Potential for Sentinel Node Biopsy
    • Increasing Integration of Artificial Intelligence in Imaging and Diagnostic Technologies Drives Adoption of Sentinel Node Biopsy Solutions
    • Regulatory Support and Approvals for Non-Invasive and Less Invasive Diagnostic Methods Strengthen Demand for Sentinel Node Biopsy Procedures
    • Increasing Preference for Lymph Node Staging Techniques That Minimize Patient Discomfort Drives Adoption of Sentinel Node Biopsy
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sentinel Node Biopsy Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Sentinel Node Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Surgical Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Surgical Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Diagnostic Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Diagnostic Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Open Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Open Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Minimally Invasive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Minimally Invasive Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Colon Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Colon Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Esophageal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Esophageal Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 28: USA Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • CANADA
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • JAPAN
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Japan 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • CHINA
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 52: China Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: China 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 54: China Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: China 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • EUROPE
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 61: Europe 6-Year Perspective for Sentinel Node Biopsy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • FRANCE
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 70: France Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: France 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 72: France Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: France 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • GERMANY
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 78: Germany Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Germany 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Italy 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • UNITED KINGDOM
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 94: UK Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: UK 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 96: UK Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: UK 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of Europe 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 118: Rest of World Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of World 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of World 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of World 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030

IV. COMPETITION